Metabolic-associated fatty liver disease (MASLD) impacts roughly 30% of people globally and has long lacked effective, targeted therapies. Now, researchers have uncovered a key genetic factor that worsens the condition. Even more surprising, the…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply